Pan Jumonji histone demethylase inhibitor (IC50
values are 230, 340, 435, 445, 855 and 1100 nM for JARID1A, JMJD2E, JMJD2B, JMJD2A, JMJD3 and JMJD2C respectively). Exhibits negligible activity at PHD2 and TET1. Selectively blocks cancer cell growth in vitro
and diminishes tumor growth in H358 and A549 mouse xenograft models in vivo
. Prolongs survival in a mouse model of breast cancer.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth.
Wang et al.
Nat. Commun., 2013;4:2035
Azinyl and diazinyl hydrazones derived from aryl N-heteroaryl ketones: synthesis and antiproliferative activity.
Grunicke and Hofmann
J. Med. Chem., 1997;40:4420
The citations listed below are publications that use Tocris products. Selected citations for JIB 04 include:
Showing Results 1 - 1 of 1